Literature DB >> 17106689

HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis.

Ashraf Bakr1, Lotfi Abdel-Naby Mahmoud, Farha Al-Chenawi, Amany Salah.   

Abstract

To investigate the association between HLA-DRB1* alleles and post-streptococcal acute glomerulonephritis (PSAGN) in Egyptian children, 32 unrelated patients with PSAGN and 380 healthy individuals from the same locality were typed for DRB1* alleles using the polymerase chain-reverse hybridization technique. Patients with PSAGN had significantly increased frequency of both DRB1* 03011 (46.9 vs. 19.2% in controls, P=0.00025) and DRB1* 1105 (31.1 vs. 15.6% in controls, P=0.0097) alleles. However, after correction of P values, only the difference for DRB1* 03011 allele remained significant (Pc=0.025). Their relative risks were significantly high (3.71, confidence interval [CI]=1.8-7.8, and 3.57, CI=1.4-8.9 respectively). No significant differences in the frequency of the two alleles were observed among patients with different grades of hypertension or proteinuria. In conclusion, DRB1* 03011, and possibly 1105, alleles confer susceptibility to PSAGN. However, the severity of the disease is not determined by these two alleles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106689     DOI: 10.1007/s00467-006-0324-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  HLA and acute poststreptococcal glomerulonephritis.

Authors:  T Sasazuki; R Hayase; I Iwamoto; H Tsuchida
Journal:  N Engl J Med       Date:  1979-11-22       Impact factor: 91.245

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  PCR-SSO typing for HLA-DRB alleles.

Authors:  R W Vaughan
Journal:  Eur J Immunogenet       Date:  1991 Feb-Apr

4.  Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B.

Authors:  J Abe; J Forrester; T Nakahara; J A Lafferty; B L Kotzin; D Y Leung
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

Review 5.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

6.  HLA and predisposition to the nonsuppurative sequelae of group A streptococcal infections.

Authors:  S E Read; H Reid; T Poon-King; V A Fischetti; J B Zabriskie; F T Rapaport
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

Review 7.  HLA-linked genes controlling immune response and disease susceptibility.

Authors:  T Sasazuki; Y Nishimura; M Muto; N Ohta
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

Review 8.  Superantigens and their potential role in human disease.

Authors:  B L Kotzin; D Y Leung; J Kappler; P Marrack
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

9.  Circulating immune complexes in patients with uncomplicated group A streptococcal pharyngitis and patients with acute poststreptococcal glomerulonephritis.

Authors:  N Yoshizawa; G Treser; J A McClung; I Sagel; K Takahashi
Journal:  Am J Nephrol       Date:  1983 Jan-Feb       Impact factor: 3.754

10.  Superantigenicity of streptococcal M protein.

Authors:  M Tomai; M Kotb; G Majumdar; E H Beachey
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  2 in total

Review 1.  New trends of an old disease: the acute post infectious glomerulonephritis at the beginning of the new millenium.

Authors:  Piero Stratta; Claudio Musetti; Antonella Barreca; Gianna Mazzucco
Journal:  J Nephrol       Date:  2014-01-31       Impact factor: 3.902

2.  Acute post-streptococcal glomerulonephritis - immune-mediated acute kidney injury - case report and literature review.

Authors:  Piotr Skrzypczyk; Anna Ofiara; Anna Zacharzewska; Małgorzata Pańczyk-Tomaszewska
Journal:  Cent Eur J Immunol       Date:  2021-12-29       Impact factor: 2.085

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.